chr8-71216757-C-T
Variant summary
Our verdict is Likely benign. The variant received -1 ACMG points: 3P and 4B. PM1PP3BS2
The NM_000503.6(EYA1):c.1295G>A(p.Arg432Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000752 in 1,461,854 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000503.6 missense
Scores
Clinical Significance
Conservation
Publications
- branchio-oto-renal syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- branchiootorenal syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- branchiootic syndrome 1Inheritance: AD Classification: STRONG Submitted by: PanelApp Australia
- branchiootic syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -1 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000503.6. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| EYA1 | NM_000503.6 | MANE Select | c.1295G>A | p.Arg432Lys | missense | Exon 14 of 18 | NP_000494.2 | ||
| EYA1 | NM_001370333.1 | c.1382G>A | p.Arg461Lys | missense | Exon 15 of 19 | NP_001357262.1 | |||
| EYA1 | NM_001370334.1 | c.1295G>A | p.Arg432Lys | missense | Exon 16 of 20 | NP_001357263.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| EYA1 | ENST00000340726.8 | TSL:1 MANE Select | c.1295G>A | p.Arg432Lys | missense | Exon 14 of 18 | ENSP00000342626.3 | ||
| EYA1 | ENST00000388742.8 | TSL:1 | c.1295G>A | p.Arg432Lys | missense | Exon 13 of 17 | ENSP00000373394.4 | ||
| EYA1 | ENST00000419131.6 | TSL:1 | c.1190G>A | p.Arg397Lys | missense | Exon 12 of 16 | ENSP00000410176.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD2 exomes AF: 0.00000398 AC: 1AN: 251350 AF XY: 0.00000736 show subpopulations
GnomAD4 exome AF: 0.00000752 AC: 11AN: 1461854Hom.: 0 Cov.: 33 AF XY: 0.00000825 AC XY: 6AN XY: 727234 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
The Arg432Lys variant in EYA1 has not been previously reported in individuals wi th hearing loss or in large population studies. Computational prediction tools a nd conservation analyses do not provide strong support for or against an impact to the protein. In summary, the clinical significance of the Arg432Lys variant i s uncertain.
Inborn genetic diseases Uncertain:1
The c.1295G>A (p.R432K) alteration is located in exon 14 (coding exon 12) of the EYA1 gene. This alteration results from a G to A substitution at nucleotide position 1295, causing the arginine (R) at amino acid position 432 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at